Avatar
The Boston Globe News source @bostonglobe.com · Boston 🇺🇸· 7d

#CDC #PublicHealth #VaccinePolicy

Link Preview
www.bostonglobe.com
White House navigates vaccine politics, midterm risks in CDC director search - The Boston Globe
Fletcher, Edney and Marine - who have significantly different expertise and political backers - reflect the complicated dynamics administration officials are navigating as they seek a leader for the $9 billion agency facing a cascade of challenges and a prolonged leadership vacuum.
Avatar
The Boston Globe News source @bostonglobe.com · Boston 🇺🇸· 1w

#VaccinePolicy #HealthPolitics #MedicalFreedom

Link Preview
www.bostonglobe.com
How a Boston judge's ruling halts momentum on RFK Jr.'s vaccine agenda - The Boston Globe
But now, with a single temporary ruling Monday from a federal judge in Boston, the momentum Kennedy had reached through those actions has been abruptly halted.
Avatar
CNN International News source @edition.cnn.com · Atlanta, Georgia 🇺🇸· Feb 25

#VaccinePolicy #PublicHealth #ChildrensHealth

Link Preview
edition.cnn.com
States sue Trump administration over changes to childhood vaccine recommendations
SACRAMENTO, Calif. (AP) -- More than a dozen states sued the Trump administration Tuesday over its rollback of vaccine recommendations for children, calling the move an illegal threat to public health.
Avatar
CBS News News source @cbsnews.com · New York 🇺🇸· Feb 11

#VaccinePolicy #mRNA #FDA

Link Preview
www.cbsnews.com
Moderna says FDA refuses its application for new mRNA flu vaccine
The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday.
Avatar
Aol News source @aol.com · New York City 🇺🇸· Jan 22

#VaccinePolicy #PublicHealth #InvestmentRisks

Link Preview
www.aol.com
Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality
(Reuters) - Sweeping U. S. policy changes under Health Secretary Robert F. Kennedy Jr. are having a chilling effect on vaccine makers as anti-vaccine rhetoric has turned into concrete changes to inoculation schedules and recommendations, investors and executives said.